AIP
DSGN icon

Ameritas Investment Partners’s Design Therapeutics DSGN Stock Holding History

Ameritas Investment Partners’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.3K Hold
2,570
– – ﹤0.01% 2446
2025
Q4 		$24.1K Hold
2,570
– – ﹤0.01% 2549
2025
Q3 		$19.4K Hold
2,570
– – ﹤0.01% 2676
2025
Q2 		$8.66K Hold
2,570
– – ﹤0.01% 3018
2025
Q1 		$9.92K Hold
2,570
– – ﹤0.01% 2827
2024
Q4 		$15.9K Hold
2,570
– – ﹤0.01% 2729
2024
Q3 		$13.8K Hold
2,570
– – ﹤0.01% 2820
2024
Q2 		$8.61K Hold
2,570
– – ﹤0.01% 2968
2024
Q1 		$10.4K Hold
2,570
– – ﹤0.01% 2805
2023
Q4 		$6.81K Hold
2,570
– – ﹤0.01% 2927
2023
Q3 		$6.07K Hold
2,570
– – ﹤0.01% 2957
2023
Q2 		$16.2K Hold
2,570
– – ﹤0.01% 2670
2023
Q1 		$14.8K Hold
2,570
– – ﹤0.01% 2568
2022
Q4 		$22K Hold
2,570
– – ﹤0.01% 2523
2022
Q3 		$42K Buy
2,570
+515
+25% +$10.2K ﹤0.01% 2108
2022
Q2 		$28K Hold
2,055
– – ﹤0.01% 2358
2022
Q1 		$33K Hold
2,055
– – ﹤0.01% 2293
2021
Q4 		$44K Buy
2,055
+998
+94% +$17.1K ﹤0.01% 2199
2021
Q3 		$16K Hold
1,057
– – ﹤0.01% 2799
2021
Q2 		$21K Buy
+1,057
New +$26.7K ﹤0.01% 2703

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameritas Investment Partners's DSGN Position: Q1 2026 in Review

Ameritas Investment Partners held its Design Therapeutics (DSGN) position steady in Q1 2026 at 2,570 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Ameritas Investment Partners first reported a position in DSGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $44K in Q4 2021. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Ameritas Investment Partners held 2,570 shares of Design Therapeutics worth $27.3K as of Q1 2026.
  • Ameritas Investment Partners left its Design Therapeutics share count unchanged in Q1 2026.
  • Design Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2446 holding.
  • Ameritas Investment Partners first reported a position in Design Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Ameritas Investment Partners's Design Therapeutics position peaked at $44K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.